Published in Int J Gynecol Cancer on June 12, 2003
Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy. Int J Clin Oncol (2008) 0.85
Prospective cohort study to evaluate the efficacy of taxane plus platinum and CPT-11plus platinum regimes and to identify prognostic risk factors in cervical cancer patients. Int J Clin Exp Med (2015) 0.77
Patient selection for neoadjuvant chemotherapy trials. Int J Gynecol Cancer (2003) 0.75
A new method for calculating evolutionary substitution rates. J Mol Evol (1984) 9.44
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg (1999) 5.25
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer (1995) 5.24
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol (1988) 3.92
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol (2001) 2.34
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol (2005) 2.29
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. Gynecol Oncol (2010) 2.27
Distant metastases in ovarian carcinoma. Int J Gynecol Cancer (2003) 2.20
Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer. Carcinogenesis (2008) 2.19
Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol (1994) 2.01
PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol (1992) 1.86
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. Ann Oncol (2002) 1.82
In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chemother Pharmacol (2000) 1.77
Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer (2007) 1.72
Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS (2000) 1.67
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer (1996) 1.66
Fine needle aspiration cytology of primary lymphoma of the thyroid: a report of 17 cases. Cytopathology (2001) 1.63
Sonographic features of decidualized ovarian endometriosis suspicious for malignancy. Ultrasound Obstet Gynecol (2004) 1.62
Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut (2001) 1.61
Retroperitoneal paragangliomas: role of immunohistochemistry in the diagnosis of malignancy and in assessment of prognosis. Eur J Surg (1994) 1.58
Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein. Ann Surg Oncol (1999) 1.51
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol (1996) 1.49
Accuracy of transvaginal sonography and contrast-enhanced magnetic resonance-colonography for the presurgical staging of deep infiltrating endometriosis. Ultrasound Obstet Gynecol (2012) 1.46
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer (2006) 1.46
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome). Ann Oncol (2007) 1.44
Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report. Gynecol Oncol (2005) 1.43
Generation of multinuclear tartrate-resistant acid phosphatase positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitors. Br J Haematol (1997) 1.42
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial. Ultrasound Obstet Gynecol (2012) 1.42
Villous adenoma of the rectum associated with malabsorption. J Clin Gastroenterol (1991) 1.41
The diagnostic potential of fetal renal biopsy. Prenat Diagn (1993) 1.40
Asymptomatic live systemic embolization observed on transesophageal echocardiography. Am Heart J (1993) 1.39
Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf) (2007) 1.38
Complete response to pre-operative chemotherapy in stage III B cervical carcinoma. Case report. Br J Obstet Gynaecol (1988) 1.37
Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis. Br J Cancer (1997) 1.33
GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer (2001) 1.27
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. Curr Cancer Drug Targets (2010) 1.25
Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer (2001) 1.24
A randomized study comparing retroperitoneal drainage with no drainage after lymphadenectomy in gynecologic malignancies. Gynecol Oncol (1997) 1.23
Fine needle aspiration cytology of the thyroid: a comparison of 5469 cytological and final histological diagnoses. Cytopathology (2006) 1.20
Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells. Prostate (2001) 1.18
Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression. Int J Cancer (1998) 1.18
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters. Br J Cancer (2005) 1.17
Is chloromethyl-X-rosamine useful in measuring mitochondrial transmembrane potential? Cytometry (1998) 1.15
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. Gynecol Oncol (2007) 1.15
Surgery by minilaparotomy in benign gynecologic disease. Obstet Gynecol (1996) 1.15
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma. J Clin Oncol (2000) 1.14
Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry (1995) 1.13
CD105 (endoglin) expression on hematopoietic stem/progenitor cells. Leuk Lymphoma (2002) 1.13
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome. Ann Oncol (1997) 1.12
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J Clin Oncol (2002) 1.12
Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations. Am J Pathol (1993) 1.12
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res (1999) 1.10
Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer (1993) 1.09
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort. Br J Cancer (2011) 1.09
Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol (1996) 1.08
Is there a place for central pancreatectomy in pancreatic surgery? J Gastrointest Surg (1999) 1.06
UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. Oncogene (2006) 1.06
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. Ann Oncol (2003) 1.06
Pure lipoma of the uterus in association with endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol (1998) 1.04
Female reproductive health in two lamp factories: effects of exposure to inorganic mercury vapour and stress factors. Br J Ind Med (1985) 1.04
Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience. Gynecol Oncol (2013) 1.04
Gene expression analysis of early and advanced gastric cancers. Oncogene (2007) 1.03
Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res (1996) 1.03
Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res (1993) 1.03
EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance. Int J Cancer (1992) 1.03
Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis (2000) 1.03
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B. Gynecol Oncol (2007) 1.03
Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors. J Infect (2001) 1.03
bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues. Clin Cancer Res (1998) 1.03
Role of gemcitabine in ovarian cancer treatment. Ann Oncol (2006) 1.03
Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol (1993) 1.02
Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res (2001) 1.02
Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am J Med Genet B Neuropsychiatr Genet (2007) 1.02
Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial. Ann Oncol (2012) 1.01
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study. Ann Oncol (2011) 1.00
Syntheses and biological activity of C-3'-difluoromethyl-taxoids. Bioorg Med Chem (2000) 1.00
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines. Br J Cancer (1999) 0.99
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer (1992) 0.99
Small-cell neuroendocrine carcinoma of the ampullary region. A clinicopathologic, immunohistochemical, and ultrastructural study of three cases. Am J Surg Pathol (1990) 0.99
Primary peritoneal carcinoma: a report of twelve cases and a review of the literature. Gynecol Obstet Invest (2000) 0.99
Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer (1991) 0.98
Metastases to the breast: role of fine needle cytology samples. Our experience with nine cases in 2 years. Ann Oncol (2007) 0.98
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. J Clin Endocrinol Metab (2004) 0.98
Deregulation of HOX B13 expression in urinary bladder cancer progression. Curr Med Chem (2013) 0.96
Operative office hysteroscopy without anesthesia: analysis of 4863 cases performed with mechanical instruments. J Am Assoc Gynecol Laparosc (2004) 0.96
p21WAF1/CIP1 protein expression in primary ovarian cancer. Int J Oncol (2000) 0.96
Lipid peroxidation products and antioxidant enzymes in red blood cells during normal and diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol (1993) 0.96
Indications and outcome for intensive care unit admission during puerperium. Arch Gynecol Obstet (2001) 0.96
Randomized clinical trial comparing systemic interferon with diathermocoagulation in primary multiple and widespread anogenital condyloma. Obstet Gynecol (1989) 0.96
Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol (2007) 0.96
A vaginoscopic approach to reduce the pain of office hysteroscopy. J Am Assoc Gynecol Laparosc (1997) 0.95
Pelvic lymphocele following radical para-aortic and pelvic lymphadenectomy for cervical carcinoma: incidence rate and percutaneous management. Obstet Gynecol (1990) 0.95
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer (1998) 0.95
Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients. Breast Cancer Res Treat (1988) 0.95
p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer. Br J Cancer (1999) 0.95
p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis. Clin Cancer Res (2000) 0.95